Supplementary Figure S1 . Body weight and Hyperinsulinemic-euglycemic clamp study in MCAT and WT mice. Body weight and age-matched animals fed regular chow or HFD and fasted overnight prior to hyperinsulinemic-euglycemic (HE) clamp study. Time-course plots of plasma glucose concentration and glucose infusion rate (GIR) in MCAT and WT mice during the HE clamp study on RC (A) and HFD (B). (C) Hepatic fatty acid oxidation measured by 14 CO 2 production from [1-14 C] oleic acid in MCAT and WT mice fed HFD for 6 weeks. Data are expressed as mean ± SEM. *P < 0.05, **P<0.01 and ***P < 0.001 by Two-Way ANOVA. NS, not significant. Whole body oxygen consumption rate (VO 2 ), (C) whole body CO 2 production rate, (D) respiratory quotients (RQ), (E) energy expenditure and (F) food intake in MCAT and WT mice on RC (left) and HFD (right) measured by a comprehensive animal metabolic monitoring system. Data are expressed as mean ± SEM. *P < 0.05, **P<0.01 and ***P < 0.001 by Two-Way ANOVA.
Supplementary
Supplementary Figure S4 . Saline infused hyperinsulinemic-euglycemic clamp study and individual intramuscular lipid species content in MCAT and WT mice.
Body weight and age-matched animals fed regular chow and fasted overnight prior to 4hr saline infusion, and then performed hyperinsulinemic-euglycemic (HE) clamp study. (A) Plasma glucose concentration and glucose infusion rate in MCAT and WT mice to maintain the euglycemia during the HE clamp study with [3mU/(kg-min)] insulin infusion. (B) Insulin stimulated whole body glucose uptake rate and (C) endogenous glucose production rate (EGP) in MCAT and WT mice (n=4) during the clamp study. (D-F) Individual intramuscular lipid species content in WT and MCAT mice after saline and liposyn infusion. (D) Intramuscular LcCoAs, (E) membrane diacylglyceride (DAG), (F) ceramides in gastrocnemius skeletal muscle after saline (n=4) and liposyn infusion (n=8 per group). Data are expressed as mean ± SEM. NS, not significant.
